Cx43 suppresses mammary tumor metastasis to the lung in a Cx43 mutant mouse model of human disease

Oncogene

Volumn 30, Issue 14, 2011, Pages 1681-1692

  Plante, I ^a   Stewart, M K G ^a   Barr, K ^a   Allan, A L ^a,b   Laird, D W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

Author keywords

connexin43; ErbB2; gap junctions; mammary gland tumor; metastasis

Indexed keywords

CONNEXIN 43; DIMETHYLBENZ[A]ANTHRACENE; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; BREAST TUMOR; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CARCINOMA; CONNEXIN 43; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MICE;

MUS;

EID: 79953767134     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.551     Document Type: Article

References (51)

1. Adriance MC, Inman JL, Petersen OW, Bissell MJ. (2005). Myo-epithelial cells: good fences make good neighbors. Breast Cancer Res 7: 190-197. (Pubitemid 41387430)
2. Allred DC, Medina D. (2008). The relevance of mouse models to understanding the development and progression of human breast cancer. J Mammary Gland Biol Neoplasia 13: 279-288.
3. Barsky SH, Karlin NJ. (2005). Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression. J Mammary Gland Biol Neoplasia 10: 249-260.
4. Bodenstine TM, Welch DR. (2008). Metastasis suppressors and the tumor microenvironment. Cancer Microenviron 1: 1-11.
5. Boggio K, Nicoletti G, Di Carlo E, Cavallo F, Landuzzi L, Melani C et al. (1998). Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice. J Exp Med 188: 589-596. (Pubitemid 28369147)
6. De Flora S, Scarfi S, Izzotti A, D'Agostini F, Chang CC, Bagnasco M et al. (2006). Induction by 7,12-dimethylbenz(a)anthracene of molecular and biochemical alterations in transformed human mammary epithelial stem cells, and protection by N-acetylcysteine. Int J Oncol 29: 521-529.
7. El-Sabban ME, Abi-Mosleh LF, Talhouk RS. (2003). Developmental regulation of gap junctions and their role in mammary epithelial cell differentiation. J Mammary Gland Biol Neoplasia 8: 463-473. (Pubitemid 39137507)
8. Engel J, Eckel R, Kerr J, Schmidt M, Furstenberger G, Richter R et al. (2003). The process of metastasisation for breast cancer. Eur J Cancer 39: 1794-1806. (Pubitemid 36897618)
9. Flenniken AM, Osborne LR, Anderson N, Ciliberti N, Fleming C, Gittens JE et al. (2005). A Gja1 missense mutation in a mouse model of oculodentodigital dysplasia. Development 132: 4375-4386. (Pubitemid 41576698)
10. Foschini MP, Eusebi V. (1998). Carcinomas of the breast showing myoepithelial cell differentiation. A review of the literature. Virchows Arch 432: 303-310. (Pubitemid 28171991)
11. Gudjonsson T, Adriance MC, Sternlicht MD, Petersen OW, Bissell MJ. (2005). Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia. J Mammary Gland Biol Neoplasia 10: 261-272.
12. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. (1992). Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89: 10578-10582.
13. Herve JC, Bourmeyster N, Sarrouilhe D, Duffy HS. (2007). Gap junctional complexes: from partners to functions. Prog Biophys Mol Biol 94: 29-65. (Pubitemid 46782980)
14. Hewitt SC, Bocchinfuso WP, Zhai J, Harrell C, Koonce L, Clark J et al. (2002). Lack of ductal development in the absence of functional estrogen receptor alpha delays mammary tumor formation induced by transgenic expression of ErbB2/neu. Cancer Res 62: 2798-2805. (Pubitemid 34525763)
15. Hirschi KK, Xu CE, Tsukamoto T, Sager R. (1996). Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 7: 861-870. (Pubitemid 26360725)
16. Husemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E et al. (2008). Systemic spread is an early step in breast cancer. Cancer Cell 13: 58-68. (Pubitemid 350309740)
17. Jacquemart IC, Springs AE, Chen WY. (2009). Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice. Int J Oncol 34: 517-528.
18. Jamieson S, Going JJ, D'Arcy R, George WD. (1998). Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. J Pathol 184: 37-43. (Pubitemid 28086151)
19. Kalra J, Shao Q, Qin H, Thomas T, Alaoui-Jamali MA, Laird DW. (2006). Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis 27: 2528-2537. (Pubitemid 44884112)
20. Kanczuga-Koda L, Sulkowski S, Lenczewski A, Koda M, Wincewicz A, Baltaziak M et al. (2006). Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol 59: 429-433.
21. Laird DW. (2006). Life cycle of connexins in health and disease. Biochem J 394: 527-543.
22. Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD et al. (1999). Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res 59: 4104-4110. (Pubitemid 29393585)
23. Lee SW, Tomasetto C, Paul D, Keyomarsi K, Sager R. (1992). Transcriptional downregulation of gap-junction proteins blocks junctional communication in human mammary tumor cell lines. J Cell Biol 118: 1213-1221.
24. Lee SW, Tomasetto C, Sager R. (1991). Positive selection of candidate tumor-suppressor genes by subtractive hybridization. Proc Natl Acad Sci USA 88: 2825-2829. (Pubitemid 21916512)
25. Manias JL, Plante I, Gong XQ, Shao Q, Churko J, Bai D et al. (2008). Fate of connexin43 in cardiac tissue harbouring a disease-linked connexin43 mutant. Cardiovas Res 80: 385-395.
26. McLachlan E, Manias JL, Gong XQ, Lounsbury CS, Shao Q, Bernier SM et al. (2005). Functional characterization of oculodentodigital dysplasia-associated Cx43 mutants. Cell Commun Adhes 12: 279-292.
27. McLachlan E, Shao Q, Laird DW. (2007). Connexins and gap junctions in mammary gland development and breast cancer progression. J Membr Biol 218: 107-121. (Pubitemid 350132123)
28. Medina D. (2007). Chemical carcinogenesis of rat and mouse mammary glands. Breast Dis 28: 63-68. (Pubitemid 350187026)
29. Mese G, Richard G, White TW. (2007). Gap junctions: basic structure and function. J Invest Dermatol 127: 2516-2524. (Pubitemid 47585051)
30. Monaghan P, Clarke C, Perusinghe NP, Moss DW, Chen XY, Evans WH. (1996). Gap junction distribution and connexin expression in human breast. Exp Cell Res 223: 29-38. (Pubitemid 26063919)
31. Nagata K, Masumoto K, Esumi G, Teshiba R, Yoshizaki K, Fukumoto S et al. (2009). Connexin43 plays an important role in lung development. J Pediatr Surg 44: 2296-2301.
32. Naoi Y, Miyoshi Y, Taguchi T, Kim SJ, Arai T, Tamaki Y et al. (2007). Connexin26 expression is associated with lymphatic vessel invasion and poor prognosis in human breast cancer. Breast Cancer Res Treat 106: 11-17. (Pubitemid 47498083)
33. Naus CC, Laird DW. (2010). Implications and challenges of connexin connections to cancer. Nat Rev Cancer 10: 435-441.
34. Paznekas WA, Karczeski B, Vermeer S, Lowry RB, Delatycki M, Laurence F et al. (2009). GJA1 mutations, variants, and connexin 43 dysfunction as it relates to the oculodentodigital dysplasia phenotype. Hum Mutat 30: 724-733.
35. Pitelka DR, Hamamoto ST, Duafala JG, Nemanic MK. (1973). Cell contacts in the mouse mammary gland. I. Normal gland in postnatal development and the secretory cycle. J Cell Biol 56: 797-818.
36. Plante I, Laird DW. (2008). Decreased levels of connexin43 result in impaired development of the mammary gland in a mouse model of oculodentodigital dysplasia. Dev Biol 318: 312-322.
37. Plante I, Wallis A, Shao Q, Laird DW. (2010). Milk Secretion and Ejection Are Impaired in the Mammary Gland of Mice Harboring a Cx43 Mutant While Expression and Localization of Tight and Adherens Junction Proteins Remain Unchanged. Biol Reprod 28: 837-847.
38. Rowse GJ, Ritland SR, Gendler SJ. (1998). Genetic modulation of neu proto-oncogene-induced mammary tumorigenesis. Cancer Res 58: 2675-2679. (Pubitemid 28275443)
39. Saunders MM, Seraj MJ, Li Z, Zhou Z, Winter CR, Welch DR et al. (2001). Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 61: 1765-1767. (Pubitemid 32691980)
40. Shao Q, Wang H, McLachlan E, Veitch GI, Laird DW. (2005). Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res 65: 2705-2711. (Pubitemid 40490071)
41. Solan JL, Lampe PD. (2005). Connexin phosphorylation as a regulatory event linked to gap junction channel assembly. Biochim Biophys Acta 1711: 154-163. (Pubitemid 40799290)
42. Solan JL, Lampe PD. (2007). Key connexin 43 phosphorylation events regulate the gap junction life cycle. J Membr Biol 217: 35-41. (Pubitemid 350160003)
43. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA et al. (1988). Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204.
44. Sternlicht MD. (2006). Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res 8: 201.
45. Sternlicht MD, Barsky SH. (1997). The myoepithelial defense: a host defense against cancer. Med Hypotheses 48: 37-46. (Pubitemid 27072863)
46. Sternlicht MD, Kedeshian P, Shao ZM, Safarians S, Barsky SH. (1997). The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 3: 1949-1958. (Pubitemid 27505120)
47. Talhouk RS, Mroue R, Mokalled M, Abi-Mosleh L, Nehme R, Ismail A et al. (2008). Heterocellular interaction enhances recruitment of alpha and beta-catenins and ZO-2 into functional gap-junction complexes and induces gap junction-dependant differentiation of mammary epithelial cells. Exp Cell Res 314: 3275-3291.
48. Thomas T, Jordan K, Simek J, Shao Q, Jedeszko C, Walton P et al. (2005). Mechanisms of Cx43 and Cx26 transport to the plasma membrane and gap junction regeneration. J Cell Sci 118: 4451-4462. (Pubitemid 41556343)
49. Tsubura A, Yoshizawa K, Uehara N, Yuri T, Matsuoka Y. (2007). Multistep mouse mammary tumorigenesis through pre-neoplasia to neoplasia and acquisition of metastatic potential. Med Mol Morphol 40: 9-17. (Pubitemid 46475024)
50. Van de Wouw AJ, Jansen RL, Speel EJ, Hillen HF. (2003). The unknown biology of the unknown primary tumour: a literature review. Ann Oncol 14: 191-196. (Pubitemid 36305428)
51. Yang M, Nonaka D. (2010). A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol 23: 654-661.